High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects

The European Respiratory Journal
Claudio SartoriU Scherrer

Abstract

High-altitude pulmonary oedema (HAPE) occurs in predisposed individuals at altitudes >2,500 m. Defective alveolar fluid clearance secondary to a constitutive impairment of the respiratory transepithelial sodium transport contributes to its pathogenesis. Hypoxia impairs the transepithelial sodium transport in alveolar epithelial type II cells in vitro. If this impairment is also present in vivo, high-altitude exposure could aggravate the constitutive defect in sodium transport in HAPE-prone subjects, and thereby further facilitate pulmonary oedema. Therefore, the aim of the current study was to measure the nasal potential difference (PD) in 21 HAPE-prone and 29 HAPE-resistant subjects at low altitude and 30 h after arrival at high altitude (4,559 m). High-altitude exposure significantly decreased the mean +/- SD nasal PD in HAPE-prone (18.0 +/- 6.2 versus 12.5 +/- 6.8 mV) but not in HAPE-resistant subjects (25.6 +/- 9.4 versus 22.9 +/- 9.2 mV). This altitude-induced decrease was not associated with an altered amiloride-sensitive fraction, but was associated with a significantly lower amiloride-insensitive fraction of the nasal PD. These findings provide evidence in vivo that an environmental factor may impair respiratory transep...Continue Reading

Citations

Oct 24, 2009·Médecine sciences : M/S·André DagenaisYves Berthiaume
Feb 9, 2007·Journal of Virology·Karl KunzelmannDavid I Cook
Nov 30, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·R Mac SweeneyD F McAuley
Aug 7, 2008·Chest·Robert B Schoene
Oct 17, 2012·Revista Española De Cardiología·Dante Penaloza
Apr 27, 2010·Progress in Cardiovascular Diseases·Urs ScherrerClaudio Sartori
Apr 27, 2010·Progress in Cardiovascular Diseases·Claudio SartoriUrs Scherrer
Apr 27, 2010·Progress in Cardiovascular Diseases·Marco Maggiorini
May 19, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Alejandro P Comellas, Arturo Briva
Jul 3, 2013·Journal of Travel Medicine·Nikolaus NetzerMartin Burtscher
Jul 3, 2007·Respiratory Physiology & Neurobiology·Yves Berthiaume, Michael A Matthay
May 29, 2007·Respiratory Physiology & Neurobiology·Claudio SartoriUrs Scherrer
Jan 2, 2007·Pulmonary Pharmacology & Therapeutics·Nicholas P Mason, Peter W Barry
Dec 13, 2005·Respiratory Physiology & Neurobiology·Heimo Mairbäurl
May 30, 2014·Journal of Occupational Health·Shuchi BhagiShashi Bala Singh
Sep 7, 2017·High Altitude Medicine & Biology·Courtney M WheatleyBruce D Johnson
Feb 11, 2005·Journal of Applied Physiology·Peter BärtschErik R Swenson
Aug 12, 2006·Journal of Applied Physiology·Eric M SnyderBruce D Johnson
Oct 29, 2015·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Anu K KaskinenOlli M Pitkänen
Jan 6, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Michael Eisenhut
May 1, 2013·British Journal of Pain·Tom Smedley, Michael Pw Grocott
Mar 23, 2010·Expert Review of Respiratory Medicine·Karen E IlesSadis Matalon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.